Overview

To Evaluate The Safety and Initial Efficacy of STSA-1002 Injection in Patients With Acute Respiratory Distress Syndrome

Status:
Recruiting
Trial end date:
2026-09-01
Target enrollment:
Participant gender:
Summary
To evaluate the safety and initial efficacy of STSA-1002 injection in patients with acute respiratory distress syndrome.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Staidson (Beijing) Biopharmaceuticals Co., Ltd